Chief Financial Officer · Inari Medical, Inc. (NARI)

Mitchell Hill

A named executive officer of Inari Medical in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,494,947

FY2022: $2,321,629

Compensation figures as of the proxy filed March 13, 2024 (DEF 14A).

Mitchell Hill compensation by year

Inari Medical Summary Compensation Table · all 3 fiscal years held
In US dollars, as Inari Medical reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$410,892$485,000$497,500
Bonus$267,150$0$0
Stock awards$1,208,505$1,510,551$1,199,072
Option awards$0$0$431,242
Non-equity incentive$0$317,190$354,000
Pension and deferred compensation$0$0$0
All other$9,374$8,889$13,133
Total$1,895,921$2,321,629$2,494,947

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Inari Medical, Inc. DEF 14A filed March 13, 2024, accession 0001193125-24-066805, and prior-year filings. Open the filing on EDGAR.

$1.9M
$2.3M
$2.5M
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU16,059$1,042,550—
RSU9,968$647,123—
RSU2,673$173,531—
RSU94,477$0—
Option12,450—$56.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Inari Medical, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Change-in-control & termination

estimated payments Inari Medical discloses, by trigger · FY2023
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Change in control, no termination$0$1,863,204$0$1,863,204
Involuntary termination without cause$375,000$0$22,127—
Change in control and involuntary termination$750,000$1,974,258$44,255—

Per the Potential Payments Upon Termination or Change in Control table in Inari Medical, Inc.'s FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.

Inari Medical’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Andrew HykesPresident, Chief Executive Officer & Director$5,083,365
Thomas TuChief Medical Officer$2,495,947
Mitchell Hill · this pageChief Financial Officer$2,494,947

The full Inari Medical compensation record

free company brief

This page is one person within Inari Medical's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Inari Medical's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Inari Medical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy